Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers.

Abstract excerpt

Background: Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, often progressing silently and leading to end-stage kidney disease (ESKD) and cardiovascular morbidity. Early identification and risk-adapted intervention are crucial to improving long-term outcomes, yet existing clinical workflows are limited by delayed diagnosis and underutilization of available therapies. Methods: We...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Diabetic Nephropathies